Judith Lindner

<i>PIK3CA</i> Mutations Are Associated With Lower Rates of Pathologic Complete Response to Anti–Human Epidermal Growth Factor Receptor 2 (HER2) Therapy in Primary HER2-Overexpressing Breast Cancer

Sibylle Loibl, Gϋnter von Minckwitz, Andreas Schneeweiß et al. · Journal of Clinical Oncology · 2014 · 247 citations · Full text

Prognostic impact of programmed cell death-1 (PD-1) and PD-ligand 1 (PD-L1) expression in cancer cells and tumor-infiltrating lymphocytes in ovarian high grade serous carcinoma

Silvia Darb‐Esfahani, Catarina Alisa Kunze, Hagen Kulbe et al. · Oncotarget · 2015 · 236 citations · Full text

Expression of secreted protein acidic and rich in cysteine (SPARC) in breast cancer and response to neoadjuvant chemotherapy

Judith Lindner, Sibylle Loibl, Carsten Denkert et al. · Annals of Oncology · 2014 · 96 citations · Full text

Secreted Protein Acidic, Breast Oncology, Biochemistry +8

SPARC expression in resected pancreatic cancer patients treated with gemcitabine: results from the CONKO-001 study

M. Sinn, B.V. Sinn, Jana K. Striefler et al. · Annals of Oncology · 2014 · 75 citations · Full text

Surgical Oncology, Pancreatic Cancer, Gastrointestinal Oncology +9

Clinical relevance and concordance of HER2 status in local and central testing—an analysis of 1581 HER2-positive breast carcinomas over 12 years

Berit M. Pfitzner, Bianca Lederer, Judith Lindner et al. · Modern Pathology · 2017 · 37 citations · Full text

Her2 Status, Breast Oncology, Medicine +8